A detailed history of National Bank Of Canada transactions in Humacyte, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 653,200 shares of HUMA stock, worth $953,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares
653,200
Previous 653,200 -0.0%
Holding current value
$953,672
Previous $1.37 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

SELL
$1.15 - $2.77 $159,390 - $383,922
-138,600 Reduced 17.5%
653,200 $1.37 Million
Q1 2025

May 12, 2025

BUY
$1.71 - $5.18 $1.35 Million - $4.1 Million
791,800 New
791,800 $1.35 Million
Q3 2024

Nov 12, 2024

BUY
$5.11 - $9.46 $10 - $18
2 New
2 $0

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $150M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.